Lidocaina Cloridrato Ogna

Lidocaine Hydrochloride, the active ingredient in Lidocaina Cloridrato Ogna, is a local anesthetic presented as a gingival preparation for topical use. It provides reversible nerve block to facilitate painless dental and oral procedures in adult patients. GNH USA supplies Lidocaina Cloridrato Ogna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is used in the oral cavity to achieve local anesthesia for a range of gingival and minor oral procedures. - Dental procedures: provides rapid, reversible numbness of gingival tissue during scaling, root planing, or restorative work. - Periodontal therapy: facilitates pain‑free access for pocket debridement and flap surgery. - Oral biopsies: enables painless removal of small mucosal lesions. - Minor oral surgeries: allows comfortable excision of benign lesions or removal of loose teeth.

Adverse reactions are generally local and dose‑related, but systemic effects can occur if absorption is excessive.

Common Side Effects: - Mild burning or stinging at the application site. - Transient numbness lasting longer than the procedure. - Localised swelling or erythema. - Taste disturbance (metallic taste). - Minor headache. - Dizziness.

Serious or Rare Side Effects: - Allergic reaction, including anaphylaxis. - Cardiac arrhythmia or conduction disturbances. - Central nervous system toxicity (seizures, tremors). - Methemoglobinemia. - Severe hypotension. - Respiratory depression.

Proper use of Lidocaine Hydrochloride requires attention to patient history and technique. - Assess allergy: verify no known hypersensitivity to amide‑type local anesthetics. - Use minimal effective amount: limit dose to recommended maximum for gingival application. - Avoid intravascular injection: aspirate before administration to reduce systemic exposure. - Monitor cardiac status: observe patients with pre‑existing heart disease for rhythm changes. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Lidocaine Hydrochloride can interact with several drug classes, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine): increase systemic toxicity risk. - Beta‑blockers: may potentiate cardiac depressant effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise plasma lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Class II antiarrhythmics (e.g., propranolol): require cardiac monitoring. - Concurrent use of other local anesthetics: cumulative toxicity possible. - Monoamine oxidase inhibitors: may enhance central nervous system effects.